QUOTE AND NEWS
Reuters  Nov 17  Comment 
* New stock repurchase program supersedes previously existing $150 million stock repurchase program through Dec 31, 2018
newratings.com  Nov 1  Comment 
WASHINGTON (dpa-AFX) - Allscripts Healthcare Solutions Inc. (MDRX) revealed a profit for its third quarter that increased compared to the same period last year. The company said its bottom line came in at $25.9 million, or $0.14 per share. This...
Benzinga  Oct 21  Comment 
Argus reiterated its Buy rating on Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) with a $19 target price as it believes new orders will translate into higher revenue over the next 12–18 months. “In particular, we are encouraged by the...
Reuters  Oct 20  Comment 
* Announces acquisition of careport; terms of transaction were not disclosed Source text for Eikon: Further company coverage:
Benzinga  Aug 23  Comment 
Leerink analyst David Larsen upgraded Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) shares from Market Perform to Outperform. The brokerage also boosted its price objective from $16 to $17. Rating Justification The lead analyst believes...
Benzinga  Aug 23  Comment 




 

Libertyville, Illinois-based Allscripts Healthcare Solutions, Inc. (MDRX) is a leading provider of clinical software and information solutions for physicians. The company has three business segments: Prepackaged Medications, Software & Related Services (SRS), and Information Services. The Prepackaged Medications segment comprises the Allscripts Direct business that offers point-of-care medication management solutions for physicians and other healthcare providers. The SRS segment includes primarily the TouchWorks software business. TouchWorks software is an Electronic Health Record (EHR) that enhances physician productivity by automating common physician activities like prescribing, dictating, capturing charges, ordering labs and viewing results, providing patient education, and documenting clinical encounters. The SRS segment also consists of Advanced Imaging Concepts (AIC), an electronic document imaging and scanning solutions business and A4 Health Systems, a provider of small practice management software solutions. The Information Services segment consists primarily of the Physicians Interactive (PI) business and the operations of RxCentric Inc. Physicians Interactive uses interactive education sessions to provide product information to the physicians, thus, linking them to pharmaceutical companies, managed care, and medical suppliers.

Business Overview

Business & Financial Metrics[1]

In 2010, MDRX generated a net income of $62.9 million on revenues of $704.5 million. This represents a 28.5% increase in net income and a corresponding 28.5% increase in revenues from 2009, when the company earned $26.0 million on $538.4 million in revenue. MDRX's fiscal year ends on May 31 of each calendar year.

Business Segments[2]

Allscripts operates through two reportable business segments.

  • Clinical Solutions (84.2% of total revenue): This segment includes the company's "Enterprise" business which targets large physician practices and its "Professional" business for smaller or independent practices.The segment primarily provides its customers with software for managing their practices or clinics.[2]
  • Health Solutions (15.8% of total revenue): This segment sells its "Emergency Department Information Systems" to hospitals and post-acute facilities like home health providers, hospices, and skilled nursing facilities.[3]

Competition[4]

The company's primary competitors in the physician healthcare information systems and services market include:

The company's primary competitors in the hospital and post-acute healthcare information systems and services market include:

  • eDischarge
  • Maxsys
  • MedHost
  • Meditech
  • Midas+
  • Picis
  • Providerlink
  • Wellsoft Corporation

References

  1. MDRX 2009 10-K pg. 41  
  2. 2.0 2.1 MDRX 2009 10-K pg. 53  
  3. MDRX 2009 10-K pg. 44  
  4. MDRX 2009 10-K pg. 11  
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki